Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001209191-23-021260

Options or other derivatives

  • Chief Financial Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Calabrese Salvatore · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-23 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +50,000 50,000 D
2023-03-23 Grant or award : show line 2 in the form Restricted Stock Units +25,000 25,000 D
Loading xslF345X04/doc4.xml…